Germany-based Oxea has begun detailed engineering on its new propanol plant at Bay City, Texas, in the US, which is scheduled to go on stream at the end of 2017.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International